Quick Takeaways
- North Peak Capital Management, LLC filed SCHEDULE 13G for Haemonetics Corporation Common stock, $.01 par value per share (HAE).
- Disclosed ownership: 5.1%.
- Date of event: 24 Feb 2026.
Quoteable Key Fact
"North Peak Capital Management, LLC disclosed 5.1% ownership in Haemonetics Corporation Common stock, $.01 par value per share (HAE) on 24 Feb 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| North Peak Capital Management, LLC | 5.1% | 2,370,495 | 0 | 1,882,037 | /s/ Jeremy Kahan | Jeremy Kahan/Managing Member | |
| North Peak Capital GP, LLC | 4% | 1,882,037 | 0 | 1,882,037 | /s/ Jeremy Kahan | Jeremy Kahan/Manager | |
| North Peak Capital Partners, LP | 0.3% | 135,354 | 0 | 135,354 | /s/ Jeremy Kahan | Jeremy Kahan/Manager of North Peak Capital GP, LLC, its General Partner | |
| North Peak Capital Partners II, LP | 2.1% | 993,566 | 0 | 993,566 | /s/ Jeremy Kahan | Jeremy Kahan/Manager of North Peak Capital GP, LLC, its General Partner | |
| North Peak Capital Alpha Fund, LP | 1.4% | 651,061 | 0 | 651,061 | /s/ Jeremy Kahan | Jeremy Kahan/Manager of North Peak Capital GP, LLC, its General Partner | |
| North Peak Capital Ultra Fund, LP | 0.2% | 102,056 | 0 | 102,056 | /s/ Jeremy Kahan | Jeremy Kahan/Manager of North Peak Capital GP, LLC, its General Partner | |
| Michael Kevin Kahan | 4% | 1,882,037 | 0 | 1,882,037 | /s/ Michael Kahan | Michael Kahan | |
| Jeremy Steven Kahan | 4% | 1,882,037 | 0 | 1,882,037 | /s/ Jeremy Kahan | Jeremy Kahan |